1. Home
  2. ABM vs IMNM Comparison

ABM vs IMNM Comparison

Compare ABM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABM Industries Incorporated

ABM

ABM Industries Incorporated

HOLD

Current Price

$44.40

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.90

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABM
IMNM
Founded
1909
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
ABM
IMNM
Price
$44.40
$23.90
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$47.80
$32.80
AVG Volume (30 Days)
764.2K
1.7M
Earning Date
06-05-2026
05-08-2026
Dividend Yield
2.92%
N/A
EPS Growth
102.34
51.40
EPS
1.37
N/A
Revenue
$8,745,900,000.00
$6,941,000.00
Revenue This Year
$5.97
N/A
Revenue Next Year
$3.45
$1,127.34
P/E Ratio
$32.31
N/A
Revenue Growth
4.62
N/A
52 Week Low
$36.96
$7.96
52 Week High
$50.12
$27.65

Technical Indicators

Market Signals
Indicator
ABM
IMNM
Relative Strength Index (RSI) 59.28 74.40
Support Level $44.50 $23.67
Resistance Level $46.53 $25.10
Average True Range (ATR) 1.18 1.06
MACD -0.12 0.68
Stochastic Oscillator 59.06 99.51

Price Performance

Historical Comparison
ABM
IMNM

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: